{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:57:23Z","timestamp":1790870243282,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20306-y","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:24:37Z","timestamp":1785338677000},"page":"9920-9931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer by Age, Race, and Tumor Subtype"],"prefix":"10.1245","volume":"33","author":[{"given":"Dalliah M.","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Glasgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Degnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina J.","family":"Hieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"6","key":"20306_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jamasurg.2020.6664","volume":"156","author":"DW Lim","year":"2021","unstructured":"Lim DW, Metcalfe KA, Narod SA. Bilateral mastectomy in women with unilateral breast cancer: a review. JAMA Surg. 2021;156(6):569\u201376.","journal-title":"JAMA Surg."},{"issue":"7","key":"20306_CR2","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/jso.26372","volume":"123","author":"FC Verdial","year":"2021","unstructured":"Verdial FC, Bartek MA, Anderson BO, Javid SH. Genetic testing and surgical treatment after breast cancer diagnosis: results from a national online cohort. J Surg Oncol. 2021;123(7):1504\u201312.","journal-title":"J Surg Oncol."},{"issue":"3","key":"20306_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10549-013-2745-1","volume":"142","author":"K Yao","year":"2013","unstructured":"Yao K, Winchester DJ, Czechura T, Huo D. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998\u20132002. Breast Cancer Res Treat. 2013;142(3):465\u201376.","journal-title":"Breast Cancer Res Treat."},{"issue":"17","key":"20306_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/djq298","volume":"102","author":"TM Tuttle","year":"2010","unstructured":"Tuttle TM, Habermann EB, Virnig B. Re: population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102(17):1371\u20132137.","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"20306_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/jnci\/djq018","volume":"102","author":"I Bedrosian","year":"2010","unstructured":"Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102(6):401\u20139.","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"20306_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1245\/s10434-023-14294-6","volume":"31","author":"C Griffin","year":"2024","unstructured":"Griffin C, Fairhurst K, Stables I, Brunsden S, Potter S. Outcomes of women undergoing mastectomy for unilateral breast cancer who elect to undergo contralateral mastectomy for symmetry: a systematic review. Ann Surg Oncol. 2024;31(1):303\u201315.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"20306_CR7","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1245\/s10434-017-5983-3","volume":"24","author":"JC Boughey","year":"2017","unstructured":"Boughey JC, Schilz SR, Van Houten HK, Zhu L, Habermann EB, Lemaine V. Contralateral prophylactic mastectomy with immediate breast reconstruction increases healthcare utilization and cost. Ann Surg Oncol. 2017;24(10):2957\u201364.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"20306_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/SLA.0000000000001698","volume":"265","author":"SM Wong","year":"2017","unstructured":"Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg. 2017;265(3):581\u20139.","journal-title":"Ann Surg."},{"issue":"4","key":"20306_CR9","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1245\/s10434-024-14893-x","volume":"31","author":"P Singh","year":"2024","unstructured":"Singh P, Agnese D, Amin M, et al. Society of surgical oncology breast disease site working group statement on contralateral mastectomy: indications, outcomes, and risks. Ann Surg Oncol. 2024;31(4):2212\u201323.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"20306_CR10","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1245\/s10434-016-5408-8","volume":"23","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy consensus statement from the American society of breast surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol. 2016;23(10):3106\u201311.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"20306_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jamcollsurg.2016.12.051","volume":"224","author":"WO Gibreel","year":"2017","unstructured":"Gibreel WO, Day CN, Hoskin TL, Boughey JC, Habermann EB, Hieken TJ. Mastectomy and immediate breast reconstruction for cancer in the elderly: a national cancer data base study. J Am Coll Surg. 2017;224(5):895\u2013905.","journal-title":"J Am Coll Surg."},{"issue":"10","key":"20306_CR12","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1245\/s10434-010-1091-3","volume":"17","author":"K Yao","year":"2010","unstructured":"Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the national cancer data base, 1998\u20132007. Ann Surg Oncol. 2010;17(10):2554\u201362.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"20306_CR13","doi-asserted-by":"publisher","first-page":"e4344","DOI":"10.1097\/GOX.0000000000004344","volume":"10","author":"MS Shaheen","year":"2022","unstructured":"Shaheen MS, Momeni A. Nationwide trends in contralateral prophylactic mastectomies: an analysis of 55,060 unilateral breast cancer patients. Plast Reconstr Surg Glob Open. 2022;10(5):e4344.","journal-title":"Plast Reconstr Surg Glob Open."},{"issue":"1","key":"20306_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jamcollsurg.2015.03.033","volume":"221","author":"L Grimmer","year":"2015","unstructured":"Grimmer L, Liederbach E, Velasco J, Pesce C, Wang CH, Yao K. Variation in contralateral prophylactic mastectomy rates according to racial groups in young women with breast cancer, 1998 to 2011: a report from the National Cancer Data Base. J Am Coll Surg. 2015;221(1):187\u201396.","journal-title":"J Am Coll Surg."},{"issue":"2","key":"20306_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/jso.26320","volume":"123","author":"DK Jackson","year":"2021","unstructured":"Jackson DK, Li Y, Eskander MF, et al. Racial disparities in low-value surgical care and time to surgery in high-volume hospitals. J Surg Oncol. 2021;123(2):676\u201386.","journal-title":"J Surg Oncol."},{"issue":"4","key":"20306_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.surg.2015.11.001","volume":"159","author":"TL Hoskin","year":"2016","unstructured":"Hoskin TL, Hieken TJ, Degnim AC, Jakub JW, Jacobson SR, Boughey JC. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery. 2016;159(4):1199\u2013209.","journal-title":"Surgery."},{"issue":"3","key":"20306_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.amjsurg.2015.03.019","volume":"210","author":"AC Kwok","year":"2015","unstructured":"Kwok AC, Goodwin IA, Ying J, Agarwal JP. National trends and complication rates after bilateral mastectomy and immediate breast reconstruction from 2005 to 2012. Am J Surg. 2015;210(3):512\u20136.","journal-title":"Am J Surg."},{"issue":"2","key":"20306_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clbc.2017.06.010","volume":"18","author":"SW Dutta","year":"2018","unstructured":"Dutta SW, Trifiletti DM, Grover S, Romano KD, Janowski EM, Showalter SL. The effect of receptor status on mastectomy and contralateral prophylactic mastectomy rates in early stage invasive breast carcinoma. Clin Breast Cancer. 2018;18(2):121\u20137.","journal-title":"Clin Breast Cancer."},{"issue":"Suppl 3","key":"20306_CR19","doi-asserted-by":"publisher","first-page":"S566","DOI":"10.1245\/s10434-015-4591-3","volume":"22","author":"I Lizarraga","year":"2015","unstructured":"Lizarraga I, Schroeder MC, Weigel RJ, Thomas A. Surgical management of breast cancer in 2010\u20132011 SEER Registries by hormone and HER2 receptor status. Ann Surg Oncol. 2015;22(Suppl 3):S566-572.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"20306_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10549-020-05964-0","volume":"185","author":"C Pesce","year":"2021","unstructured":"Pesce C, Jaffe J, Kuchta K, Yao K, Sisco M. Patient-reported outcomes among women with unilateral breast cancer undergoing breast conservation versus single or double mastectomy. Breast Cancer Res Treat. 2021;185(2):359\u201369.","journal-title":"Breast Cancer Res Treat."},{"issue":"8","key":"20306_CR21","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1245\/s10434-012-2299-1","volume":"19","author":"A Chung","year":"2012","unstructured":"Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19(8):2600\u20136.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"20306_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.surg.2019.05.055","volume":"166","author":"A Sada","year":"2019","unstructured":"Sada A, Day CN, Hoskin TL, Degnim AC, Habermann EB, Hieken TJ. Mastectomy and immediate breast reconstruction in the elderly: trends and outcomes. Surgery. 2019;166(4):709\u201314. https:\/\/doi.org\/10.1016\/j.surg.2019.05.055.","journal-title":"Surgery."},{"issue":"9","key":"20306_CR23","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.21037\/gs-22-759","volume":"12","author":"N Owusu-Brackett","year":"2023","unstructured":"Owusu-Brackett N, Aduwo J, Relation TS, et al. Trends in utilization of contralateral prophylactic mastectomy among different age, racial and ethnic groups. Gland Surg. 2023;12(9):1224\u201332.","journal-title":"Gland Surg."},{"issue":"4","key":"20306_CR24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/tbj.13293","volume":"25","author":"SP Lazow","year":"2019","unstructured":"Lazow SP, Riba L, Alapati A, James TA. Comparison of breast-conserving therapy vs mastectomy in women under age 40: national trends and potential survival implications. Breast J. 2019;25(4):578\u201384.","journal-title":"Breast J."},{"issue":"6","key":"20306_CR25","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, et al. Breast cancer statistics 2024. CA Cancer J Clin Nov-Dec. 2024;74(6):477\u201395.","journal-title":"CA Cancer J Clin. Nov-Dec"},{"key":"20306_CR26","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists' Collaborative Group. Electronic address bocoau. Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials. Lancet. 2024;404(10461):1407-1418.","DOI":"10.1016\/S0140-6736(24)01745-8"},{"issue":"1","key":"20306_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/cancers12010140.PMID:31935898;PMCID:PMC7016894","volume":"12","author":"V Teoh","year":"2020","unstructured":"Teoh V, Tasoulis MK, Gui G. Contralateral prophylactic mastectomy in women with unilateral breast cancer who are genetic carriers, have a strong family history or are just young at presentation. Cancers (Basel). 2020;12(1):140. https:\/\/doi.org\/10.3390\/cancers12010140.PMID:31935898;PMCID:PMC7016894.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"20306_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/XCS.0000000000001089","volume":"239","author":"A Vadlakonda","year":"2024","unstructured":"Vadlakonda A, Curry J, Gao Z, et al. Current status of contralateral prophylactic mastectomy: investigating structural racial disparity. J Am Coll Surg. 2024;239(3):253\u201362.","journal-title":"J Am Coll Surg."},{"issue":"9","key":"20306_CR29","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1245\/s10434-014-3712-8","volume":"21","author":"A Ashfaq","year":"2014","unstructured":"Ashfaq A, McGhan LJ, Pockaj BA, et al. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy. Ann Surg Oncol. 2014;21(9):2934\u201340.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"20306_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.surg.2023.09.015","volume":"175","author":"JA Steadman","year":"2024","unstructured":"Steadman JA, Hoskin TL, Klassen C, Boughey JC, Degnim AC, Piltin MA, Mrdutt MM, Johnson JE, Hieken TJ. Assessment of the effect of the American society of breast surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer. Surgery. 2024;175(3):677\u201386. https:\/\/doi.org\/10.1016\/j.surg.2023.09.015.","journal-title":"Surgery."},{"issue":"10","key":"20306_CR31","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1245\/s10434-014-3924-y","volume":"21","author":"EB Habermann","year":"2014","unstructured":"Habermann EB, Thomsen KM, Hieken TJ, Boughey JC. Impact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample. Ann Surg Oncol. 2014;21(10):3290\u20136.","journal-title":"Ann Surg Oncol."},{"key":"20306_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jss.2024.03.010","volume":"298","author":"CM Lattimore","year":"2024","unstructured":"Lattimore CM, Meneveau MO, Desai R, Camacho TF, Squeo GC, Showalter SL. Are there disparities in breast reconstruction after contralateral prophylactic mastectomy? J Surg Res. 2024;298:277\u201390.","journal-title":"J Surg Res."},{"key":"20306_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.breast.2021.02.003","volume":"56","author":"JCC Scheepens","year":"2021","unstructured":"Scheepens JCC, Veer LV, Esserman L, Belkora J, Mukhtar RA. Contralateral prophylactic mastectomy: a narrative review of the evidence and acceptability. Breast. 2021;56:61\u20139.","journal-title":"Breast."},{"issue":"5","key":"20306_CR34","first-page":"359","volume":"31","author":"LA Newman","year":"2017","unstructured":"Newman LA. Decision making in the surgical management of invasive breast cancer-part 1: lumpectomy, mastectomy, and contralateral prophylactic mastectomy. Oncology (Williston Park). 2017;31(5):359\u201368.","journal-title":"Oncology (Williston Park)."},{"issue":"10","key":"20306_CR35","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1245\/s10434-016-5443-5","volume":"23","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks. Ann Surg Oncol. 2016;23(10):3100\u20135.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"20306_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12905-017-0366-2","volume":"17","author":"DF Baptiste","year":"2017","unstructured":"Baptiste DF, MacGeorge EL, Venetis MK, et al. Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status. BMC Womens Health. 2017;17(1):10.","journal-title":"BMC Womens Health."},{"issue":"13","key":"20306_CR37","doi-asserted-by":"publisher","first-page":"8752","DOI":"10.1245\/s10434-021-10426-y","volume":"28","author":"IM Lizarraga","year":"2021","unstructured":"Lizarraga IM, Schroeder MC, Jatoi I, Sugg SL, Trentham-Dietz A, Hoeth L, Chrischilles EA. Surgical decision-making surrounding contralateral prophylactic mastectomy: comparison of treatment goals, preferences, and psychosocial outcomes from a multicenter survey of breast cancer patients. Ann Surg Oncol. 2021;28(13):8752\u201365.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"20306_CR38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamasurg.2016.4749","volume":"152","author":"R Jagsi","year":"2017","unstructured":"Jagsi R, Hawley ST, Griffith KA, et al. Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg. 2017;152(3):274\u201382.","journal-title":"JAMA Surg."},{"key":"20306_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jss.2024.09.071","volume":"303","author":"BK He","year":"2024","unstructured":"He BK, Chu CD, Smith CE, Lefbom L, Schroen A. Trends in contralateral prophylactic mastectomies before and after the American society of breast surgeons consensus statement. J Surg Res. 2024;303:545\u201353.","journal-title":"J Surg Res."},{"issue":"6","key":"20306_CR40","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1245\/s10434-025-17185-0","volume":"32","author":"A Weiss","year":"2025","unstructured":"Weiss A, Rosito MS, Braun D, Barton B, McGrath M, Stokes S, Laws A, Warren L, Morganti S, Lynce F, Bychkovsky B, Rana HQ, Davis D, Stopfer J, Garber JE, King TA. Impact of the American society of breast surgeons\u2019 guidelines on genetic testing and contralateral prophylactic mastectomy rates. Ann Surg Oncol. 2025;32(6):3965\u201374.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"20306_CR41","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1245\/s10434-020-08889-6","volume":"27","author":"BL Murphy","year":"2020","unstructured":"Murphy BL, Yi M, Arun BK, Gutierrez Barrera AM, Bedrosian I. Contralateral risk-reducing mastectomy in breast cancer patients who undergo multigene panel testing. Ann Surg Oncol. 2020;27(12):4613\u201321.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"20306_CR42","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/jnci\/djaa040","volume":"112","author":"JR Palmer","year":"2020","unstructured":"Palmer JR, Polley EC, Hu C, John EM, Haiman C, Hart SN, Gaudet M, Pal T, Anton-Culver H, Trentham-Dietz A, Bernstein L, Ambrosone CB, Bandera EV, Bertrand KA, Bethea TN, Gao C, Gnanaolivu RD, Huang H, Lee KY, LeMarchand L, Na J, Sandler DP, Shah PD, Yadav S, Yang W, Weitzel JN, Domchek SM, Goldgar DE, Nathanson KL, Kraft P, Yao S, Couch FJ. Contribution of germline predisposition gene mutations to breast cancer risk in African American women. J Natl Cancer Inst. 2020;112(12):1213\u201321.","journal-title":"J Natl Cancer Inst."},{"issue":"9","key":"20306_CR43","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, Feng B, McFarland R, Pesaran T, Huether R, LaDuca H, Chao EC, Goldgar DE, Dolinsky JS. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3(9):1190\u20136.","journal-title":"JAMA Oncol."},{"issue":"29","key":"20306_CR44","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1200\/JCO.2006.10.4703","volume":"25","author":"KJ Vogel","year":"2007","unstructured":"Vogel KJ, Atchley DP, Erlichman J, Broglio KR, Ready KJ, Valero V, Amos CI, Hortobagyi GN, Lu KH, Arun B. BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol. 2007;25(29):4635\u201341.","journal-title":"J Clin Oncol."},{"issue":"2","key":"20306_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/JCO.2011.41.0027","volume":"31","author":"JN Weitzel","year":"2013","unstructured":"Weitzel JN, Clague J, Martir-Negron A, Ogaz R, Herzog J, Ricker C, Jungbluth C, Cina C, Duncan P, Unzeitig G, Saldivar JS, Beattie M, Feldman N, Sand S, Port D, Barragan DI, John EM, Neuhausen SL, Larson GP. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the clinical cancer genetics community research network. J Clin Oncol. 2013;31(2):210\u20136.","journal-title":"J Clin Oncol."},{"issue":"Suppl 1","key":"20306_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10552-023-01689-9","volume":"34","author":"MM Wahlen","year":"2023","unstructured":"Wahlen MM, Lizarraga IM, Kahl AR, et al. Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer. Cancer Causes Control. 2023;34(Suppl 1):171\u201386.","journal-title":"Cancer Causes Control."},{"issue":"2","key":"20306_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1089\/jwh.2018.7350","volume":"29","author":"B Jerome-D'Emilia","year":"2020","unstructured":"Jerome-D\u2019Emilia B, Trinh H. Socioeconomic factors associated with the receipt of contralateral prophylactic mastectomy in women with breast cancer. J Womens Health (Larchmt). 2020;29(2):220\u20139.","journal-title":"J Womens Health (Larchmt)."},{"key":"20306_CR48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.sopen.2024.02.007","volume":"18","author":"DJ Clegg","year":"2024","unstructured":"Clegg DJ, Whiteaker EN, Salomon BJ, et al. Contralateral prophylactic mastectomy in a rural population: a single-institution experience. Surg Open Sci. 2024;18:70\u20137.","journal-title":"Surg Open Sci."},{"issue":"10","key":"20306_CR49","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1245\/s10434-017-5985-1","volume":"24","author":"EP Ward","year":"2017","unstructured":"Ward EP, Unkart JT, Bryant A, Murphy J, Blair SL. Influence of distance to hospital and insurance status on the rates of contralateral prophylactic mastectomy, a National Cancer Data Base study. Ann Surg Oncol. 2017;24(10):3038\u201347.","journal-title":"Ann Surg Oncol."},{"key":"20306_CR50","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijsu.2017.12.022","volume":"50","author":"R Kenny","year":"2018","unstructured":"Kenny R, Reed M, Subramanian A. Mastectomy for risk reduction or symmetry in women without high-risk gene mutation: a review. Int J Surg. 2018;50:60\u20134.","journal-title":"Int J Surg."},{"issue":"4","key":"20306_CR51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejso.2011.12.014","volume":"38","author":"U G\u00fcth","year":"2012","unstructured":"G\u00fcth U, Myrick ME, Viehl CT, et al. Increasing rates of contralateral prophylactic mastectomy\u2014a trend in the USA? Eur J Surg Oncol. 2012;38(4):296\u2013301.","journal-title":"Eur J Surg Oncol."},{"issue":"8","key":"20306_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003179","volume":"3","author":"J Neuburger","year":"2013","unstructured":"Neuburger J, Macneill F, Jeevan R, van der Meulen JH, Cromwell DA. Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics. BMJ Open. 2013;3(8):e003179.","journal-title":"BMJ Open."},{"issue":"9","key":"20306_CR53","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1245\/s10434-021-09855-6","volume":"28","author":"KA Metcalfe","year":"2021","unstructured":"Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T, Wright F, Demsky R, Mancuso T, Sun P, Narod SA. Frequency of contralateral prophylactic mastectomy in breast cancer patients with a negative BRCA1 and BRCA2 rapid genetic test result. Ann Surg Oncol. 2021;28(9):4967\u201373.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"20306_CR54","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41598-021-82654-x","volume":"11","author":"NN Basu","year":"2021","unstructured":"Basu NN, Hodson J, Chatterjee S, Gandhi A, Wisely J, Harvey J, Highton L, Murphy J, Barnes N, Johnson R, Barr L, Kirwan CC, Howell S, Baildam AD, Howell A, Evans DG. The Angelina Jolie effect: contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer. Sci Rep. 2021;11(1):2847.","journal-title":"Sci Rep."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20306-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20306-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20306-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:19:31Z","timestamp":1790867971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20306-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20306"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20306-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}